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Pharmacists and their pharmacies have been evolving in their roles as health promoters in Brazil. Some 
examples are the recent legislation reaffirming the role of Brazilian pharmacies as health institutions, 
rather than having only a commercial profile, giving greater clarity to pharmacists about their roles as 
health care providers. This evolution came with the recognition that is already seen in other developed 
countries, confirming the need for the pharmacist as a health promoter, and not simply a dispenser 
of drugs in society. This study has obtained the profile and activities of community pharmacists, 
as well as the quality indicators of private community pharmacies throughout the State of Paraná 
through the application of an online survey sent to pharmacists in the state. Out of all pharmacists 
surveyed, 533 were part of the final analysis, being the pharmacists to complete the survey in full. 
Participants were mostly female (69.4%) and were, on average, 35.2 ± 9.2 years old. Of these, 60% 
worked in pharmacy chains and just 37% of all pharmacist respondents were issuing the Declaration of 
Pharmaceutical Services. The current study showed that many pharmaceutical services are not adopted 
by pharmacies as these services bring no significant financial reward. Regarding the structure, the 
Paraná State showed that pharmacies present a good overall structure. The kind of pharmacy (chain or 
independent) influenced the pharmaceutical services provided and the available structure, where the 
independent pharmacies provide a wider range of services and have better structure. This study was 
able to identify the profile and behaviors of pharmacists and also the quality indicators of pharmacies in  
Paraná State.
Uniterms: Pharmaceutical care. Pharmacists/professional practice. Community pharmacy/structure 
indicators/Paraná State, Brazil.
INTRODUCTION
The pharmaceutical profession has undergone 
important changes in the last few decades in Brazil, 
especially in relation to community pharmacies, with 
changing roles and a focus on providing clinical services 
to patients. 
The pharmacy, as commercial establishment, has 
evolved significantly (França Filho et al., 2008; Silva, 
Vieira, 2004), with regulatory advancements such as the 
publication of law 13.021/14, which inverts the profit 
oriented logic, by defining the pharmacy as a health 
care entity geared toward providing a pharmaceutical 
service, and technical and clinical assistance, to promote 
the best health care for the patients (Brasil, 2014; 
Souza, 2012).
The term service refers to a set of activities 
organized in a work process. In a broad definition, 
pharmaceutical services represent any particular service 
provided by pharmacists and they may be clinical or 
not. The pharmaceutical care includes a wide range 
of clinical services, ranging from the benchmarks to 
pharmacotherapeutic monitoring itself. Recently, in order 
to clarify definitions and guide professional activity, the 
Federal Council of Pharmacy (CFF) – National Pharmacy 
Council – in 2013 published the resolutions 585 and 586, 
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which regulate the attributions of clinical pharmacists and 
of pharmaceutical prescription.
The importance of pharmaceutical services has 
been recognized by various studies (Blenkinsopp, Bond, 
Raynor, 2012; Castelino, Bajorek, Chen, 2010; Krska et 
al., 2001), which indicate improvements in the profile 
of medication usage (Castelino, Bajorek, Chen, 2010; 
Cobb, 2014; Cramer, 2004; Gellad, Grenard, Mcglynn, 
2009; Hatah et al., 2014; Machado et al., 2007b), clinical 
outcomes  (Charrois et al., 2009; Machado et al., 2007a; 
Santschi et al., 2012; Sookaneknun et al., 2004; Wubben, 
Vivian, 2008), humanistic outcomes (Garrett, Bluml, 
2005; Singhal et al., 1999) and economical outcomes  
(Altowaijri, Phillips, Fitzsimmons, 2013; Cranor, 
Christensen, 2003; Desborough et al., 2012; Gallagher et 
al., 2015; Garrett, Bluml, 2005; Riley, 2013), in numerous 
chronic conditions, besides the level of evident patient 
satisfaction. As such, many countries, including the 
United States, Canada and the United Kingdom, have 
added clinical pharmaceutical services to their healthcare 
systems. These services have allowed polymedicated 
patients, patients with chronic conditions and patients with 
comprehension or cognitive difficulties to have access to 
individual appointments for pharmacotherapy revision and 
pharmacotherapeutic follow up.
These systems present well defined financial 
precepts, in which the professionals and establishments 
are remunerated according to the health care activities 
they provide (Blake, Madhavan, 2010; Latif, Pollock, 
Boardman, 2011; NHS, 2008,2009; Riley, 2013). 
Quality is a determining factor for the success of any 
clinical service and, as such, a good general structure, 
accompanied by a good work process, increases the 
success chances of a pharmaceutical care service. A 
structure comprised of a good human resources team, 
good facilities and material and financial resources paired 
together with a good process, in which the professional 
is enabled and confident and interacts appropriately with 
their patient, tends to produce more positive health care 
outcomes (Donabedian, 2005; Vuori, 1991).
In Brazil, despite recent advancements, it is still 
under development in terms of pharmaceutical care, the 
initiatives are independent and uncoordinated, and there 
are numerous discrepancies among different regions, 
in terms of the profile of professionals and of the work 
processes that are adopted. Whereas overviews of the 
pharmaceutical activity in Paraná State are few and short, 
the objective of this study is to characterize the profiles 
and activities of community pharmacists, as well as the 
quality indicators of private community pharmacies in 
Paraná State - Brazil.
METHODS
In order to conduct this transversal study, email 
addresses from all active pharmacists in the State of 
Paraná were obtained from the Conselho Regional de 
Farmácia do Paraná (CRF-PR), and these professionals 
were surveyed in the period of time from October 2013 to 
January 2014 through the tool SurveyMonkey®.
Structure of the questionnaire
The questionnaire consisted of both open- and 
closed-ended questions, organized into sections: 
sociodemographic data, work process and dynamics and 
pharmaceutical services provided. 
The section on sociodemographic data consisted 
of questions pertaining to gender, age, city of activity, 
number of pharmacies/drugstores where the professional 
works, weekly workload in hours, experience time in 
drugstores, year of graduation, education level, type of 
technical responsibility and pharmacy ownership. The 
preference of pharmacists between management area or 
technical assistance was assessed through a question with 
three possible answers and these possible answers were 
the preference for management area, technical assistance 
or both.
The section on work process and dynamics consisted 
of questions pertaining to indicators of structure, in 
accordance with various works (Cipolle, Strand, Morley, 
1998; Farris, Kirking, 1993; Machuca, Fernández-
llimós, Faus, 2003), such as appropriate conditions for 
pharmaceutical care, which includes Internet access, 
human resources, equipment, facilities, financial resources 
and material resources. 
The section on pharmaceutical services provided 
consisted mainly of questions pertaining to the 
technical regulation on ‘Good Practices in Pharmacy’ 
by the Conselho Federal de Farmácia (CFF, 2001) 
and Resolution 44, from August 17th, 2009, by the 
Diretoria Colegiada da Agência Nacional de Vigilância 
Sanitária (ANVISA) (Brasil, 2001; Brasil, 2009). These 
include dispensing the provision of pharmaceutical 
services and the issuance of the Declaração de Serviços 
Farmacêuticos - DSF (Declaration of Pharmaceutical 
Services – DPS), that is the product of any service or 
procedure provided to patients. It is a document that 
contains all procedures and services performed by 
the pharmacist in order to ensure safety and access to 
information to patients. It also provides to the pharmacist 
a “memory” of what was done, and provides for future 
follow-up actions.
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Data analysis
Data analysis was performed on the software SPSS®, 
version 20.0 (SPPS Inc., Chicago, IL). The answers to this 
questionnaire were collected from the online platform. 
Only the complete questionnaires were then put through 
descriptive and inferential statistical analyses. Variables 
were tested according to their normality, and based on 
these data the appropriate statistical tests were selected.
Descriptive analyses included the frequency, 
which was demonstrated by percentages, mean, median, 
standard deviation and interquartile interval (defined by 
the percentile 25 and percentile 75).
Scores were created for the variables of structure and 
of provision of service. In order to establish the score for 
structure, the following variables related to the pharmacy 
were considered: availability of seating area for clients 
awaiting care, availability of private or semi-private space 
for tending to clients and availability of work equipment, 
such as a computer, Internet access and a printer. As 
such, the score for structure varies from 0 (no structure 
available) up to 5 (all essential structural assets available).
The scores for pharmaceutical services were obtained 
from the eight services included in the survey, which were: 
application of injectables, blood pressure measurements, 
ear piercing, body temperature measurements, capillary 
blood glucose measurements, home care, bandaging 
and application of a nebulizer. The scores varied from 
0 (no pharmaceutical service provided) to 8 (eight 
pharmaceutical services provided). 
Another variable was the MHDI (municipal human 
development index), an adaptation of the global HDI 
(human development index) to be used for Brazilian cities, 
with three main focus points: long and healthy life, access 
to knowledge and dignified standard of living through 
income (PNUD, 2014). This variable was binary: cities of 
high and very high MHDI were combined into one group 
and cities with medium and low MHDI were combined 
into another group. 
Some of the variables were transformed from the 
initial data in order to concentrate characteristics in a 
higher or more balanced number of participants. In this 
context, the modified education level – originally there 
were four levels, undergraduate, graduate, master’s 
and Ph.D., which were separated into two groups 
(graduation and post-graduation) – is of note. The scores 
for pharmaceutical services were also transformed by 
removing the pharmacists who did not provide any 
of the pharmaceutical services. As a result, the score, 
which was named ‘Score services 8’, varies from 1 
(one pharmaceutical service provided) up to 8 (eight 
pharmaceutical services provided).
The variable for type of pharmacy was also grouped, 
in order to separate independent pharmacies from the 
others. The variable was then named ‘Type of pharmacy 
V2’, characterizing pharmacies as either independent 
pharmacies or chain pharmacies (local, state and national 
chains). 
This study is in accordance with norms for research 
with human beings and was approved by the Committee 
of Ethics in Research (Comitê de Ética em Pesquisa – 
COEP) of the Universidade Estadual de Ponta Grossa, 
under number 316,374/2013. 
RESULTS AND DISCUSSION
A total of 12,401 email addresses were obtained from 
the information provided by CRF-PR. After removal of 
duplicates, 9,837 email addresses remained, of which 952 
were returned (email address nonexistent or unavailable) 
and were removed, resulting in 8,885 email addresses to be 
used in the survey. After invitations for participating in the 
survey were sent, 1,851 pharmacists responded (20.8%), 
and 533 of these complete the survey in full. 
The distribution of respondents was considerably 
homogeneous throughout the State of Paraná, with 
responses from 158 different cities (Figure 1).
Pharmacists were predominantly female (69.4%), 
with an average age of 35.2 ± 9.2 years and average 
years in education of 11.4 ± 8.2 years (Table I). Most 
pharmacists (the majority of respondents) were located 
in cities with high/very high MHDI (83.7%).
Statistical analysis between genders showed that 
women predominated in the post-graduate group, with 
54.1% of women being in this group versus 41.7% of men 
(χ²=6.888, p<0.05). Men, on the other hand, had more 
experience in retail and had been graduated for longer, 
p<0.05. Regarding provision of pharmaceutical services, 
95.1% of men versus 85.1% of women (χ²=10.762, 
p<0.05) provided pharmaceutical services. Regarding the 
transformed variables ‘Score of services 8’ and ‘Score of 
structure’, men belonging to these pharmacies had a higher 
general score in both, p<0.05, this may demonstrate that 
the level of study has less influence than the experience in 
retail on the provision of pharmaceutical services.
Regarding education level, 50.2% of pharmacists had 
some kind of post-graduate training. This is higher than 
similar surveys have found in other states of Brazil and 
even in other countries (França Filho et al., 2008; Correr 
et al., 2004; Hughes et al., 2010; Khan, 2015; Reis, 2013).
The cross-analysis of the modified variable education 
level versus both ‘Score of structure’ and ‘Score of 
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services 8’ revealed that pharmacists with a post-graduate 
level of education had higher scores in both, p<0.05 and 
p=0.057 respectively. This shows that education level 
tends to influence both structure (pharmacists with post-
graduate qualification select better structures or transform 
the existing one) and provision of pharmaceutical services 
(number of pharmaceutical services provided). This data 
can be explained considering that the higher level of 
education provides pharmacists with the skills to provide 
better pharmaceutical care services. Moreover, more time 
in educational institutions can awaken a critical thinking 
among professionals.
The analysis of the type of pharmacy where 
pharmacists worked revealed that 60% were part of some 
sort of pharmacy chain. These pharmacists had a median 
of 2 assistants and usually worked their work shift alone 
(65.1%). 
Cross-analysis of the type of pharmacy versus 
MHDI revealed that in cities with medium and low 
MHDI, pharmacies that were part of national chains 
were the least present, followed by pharmacies that were 
part of state chains, 5.2% and 10.4%, respectively (χ² = 
17,345, p<0.05). Additionally, the analysis of the binary 
variable of the type of pharmacy versus provision of 
pharmaceutical services showed that chain pharmacies 
were more predominant in the group that does not 
provide pharmaceutical services, 17.5% versus 3.3% for 
independent pharmacies (χ²=24,787, p<0.05).
Evaluation of the type of pharmacy, binary variable, 
in relation to the variables ‘Score of structure’ and 
‘Score of services 8’, revealed that chain pharmacies 
scored lower in both cases. This shows that independent 
pharmacies have better structure for provision of 
pharmaceutical services and that they also provide more 
pharmaceutical services. This may be explained by the 
fact that independent pharmacies have higher rates of 
ownership by pharmacists than do chain pharmacies, 
57.5% versus 42.5%, respectively.
In the Paraná State, pharmacists presented similar 
preferences towards the management and administration 
area and towards the technical or assistance area (interest 
in both areas 58.2%). This differs from the State of Santa 
Catarina, where pharmacists have higher preference for the 
technical or assistance area (França Filho et al., 2008). When 
time since graduation of pharmacists is taken into account in 
the analyses, more recently graduated pharmacists show a 
higher level of interest in the managerial/administrative area 
(p<0.05). This may be explained by the lack of experience 
of recently graduated professionals in providing services. 
According to respondents, 42.8% of customers 
are attended directly by the pharmacists. Furthermore, 
in a regular work week the pharmacist spends 4 hours 
on average performing activities related to the SNGPC 
(Sistema Nacional de Gerenciamento de Produtos 
Controlados - National Management System for 
Controlled Products). These numbers show a worrisome 
reality, in which less than half of patients had access to 
the pharmacists, and indicate the need for an increase in 
trained human resources and of work hours dedicated 
to clinical activities in order to provide effective 
FIGURE 1 - Distribution of respondents in the State of Paraná.
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pharmaceutical attendance. The second piece of data 
shows that pharmacists cannot blame the SNGPC for 
taking time away from customers.
When the structure of the pharmacies where the 
pharmacists worked was considered, the pharmacies 
in Paraná State had good structure available in general 
(Figure 2), even when compared to studies published in 
other states, such as Santa Catarina, São Paulo and Espírito 
Santo (França Filho et al., 2008; Tomassi, Ribeiro, 2012; 
Fernandes, 2014). However, almost 50% of pharmacists 
did not have access to a private or semi-private space for 
tending to customers, which compromises the quality of 
the services provided and is far from ideal. 
When asked about which pharmaceutical services 
were provided, there was a prevalence of services for blood 
pressure measurement and application of injectables. 
Figure 3 shows the (abbreviated) frequency data for the 
application of injectables, blood pressure measurement, 
ear piercing, body temperature measurement, capillary 
blood glucose test, home services, bandaging and 
administration of nebulizers, which were in accordance 
with previous data publications regarding the state capital 
of Paraná (Correr et al., 2004). In the State of Santa 
Catarina, the percentages are similar, except for the blood 
glucose test, which was 4 times higher than in the Paraná 
State  (França Filho et al., 2008).
The survey also gathered data regarding the number 
of procedures performed per week and the price for such 
procedures. Blood pressure measurement and application 
of injectables were the services with the highest medians of 
frequency, of 30 and 14 weekly procedures, respectively. 
The other services had a weekly frequency of ≤ 6. The 
services with the highest prices were ear piercing and 
home services, both with a median of R$10.00, whereas 
other services had prices ≤ R$5.00, which shows that 
pharmaceutical services are undervalued. 
Regarding the issuance of the Declaration of 
Pharmaceutical Services (DPS), only 37% of professionals 
issue the DPS, which shows that most pharmacists are 
not following the current law (Brasil, 2009). Other 
studies have also shown this tendency of not abiding 
by law (Fernandes, 2014; Reis, 2013). In Brazil, the 
pharmaceutical services statement is considered an 
important product of pharmaceutical services, it ensures 
that the patient has access to data on the services and 
procedures performed, ensuring traceability and safety 
of pharmacotherapy, as well as empowering the patient 
in relation to their care. The low utilization of this official 
document may reflect a lack of knowledge regarding the 
regulatory laws of the profession, rather than an actual 
oversight.
The analysis of the MHDI variable versus the 
variables of ‘Score of structure’ and ‘Score of services 
8’ showed that, surprisingly, the cities with an MHDI 
classification of medium or low had the highest scores 
both for structure and for services provided, p<0.05. This 
result shows that the pharmacies in these cities have better 
structure for provision of pharmaceutical services and also 
provide more pharmaceutical services than cities with high 
or very high MHDI. 
This situation can be explained by the higher 
prevalence of independent pharmacies in cities with 
lower MDHI, which can facilitate a more intimate 
contact with the patient, leading to bonding and 
customer fidelity and to a prioritization of the clinical 
rather than the commercial aspects of pharmaceutical 







Specialization or MBA 245 (46.0)
Master’s degree 20 (3.8)
PhD 3 (0.6)
Type of pharmacy
Local/regional pharmacy chain 174 (32.6)
State pharmacy chain 49 (9.2)
National pharmacy chain 97 (18.2)
Independent pharmacy 213 (40.0)
Type of responsibility
Technical director pharmacist 233 (43.7)
Owner pharmacist 167 (31.3)
Manager pharmacist 114 (21.4)
Technical assistant pharmacist 102 (19.1)
Substitute pharmacist 38 (7.1)
Experience time working in retail
0-10 years 327 (61.4)
11-20 years 138 (25.9)
21-30 years 58 (10.9)
31 years or more 10 (1.9)
Areas of interest
Technical/assistance area 160 (30.0)
Administration/management area 63 (11.8)
Both areas 301 (58.2)
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activities. Furthermore, cities with a lower MHDI tend 
to be lacking in health care services. In this context, the 
pharmacy is the closest, if not the only, alternative for 
the resolution of problems, which leads to a higher need 
for pharmaceutical services. 
CONCLUSIONS
In the present study, pharmacists from community 
pharmacies in the State of Paraná showed a great interest 
in further education (post-graduate training). Men were 
found to provide more pharmaceutical services and 
to work in pharmacies with better structure for these 
services, despite being more represented in the group 
with the lowest degree of specialization. The structure of 
pharmacies in Paraná State is in a general manner good, 
but still far from ideal. 
Responses  to  the  survey have shown that 
pharmaceutical services are poorly adopted and are 
evidently undervalued in Paraná State. They have also 
revealed that few pharmacists correctly follow the 
legislation and issue the DPS.
The larger chain pharmacies, both national and state-
wide, provide fewer pharmaceutical services and have 
worse structure for the provision of these services when 
compared to independent pharmacies. Chain pharmacies 
are also more prevalent in cities with higher MHDI, 
showing a primarily commercial focus, however, the 
publication of the law 13,021 in 2014, which defines the 
pharmacy as a health institution, and the recent expansion 
FIGURE 2 - Indicators of structure of community pharmacies in the State of Paraná.
FIGURE 3 - Pharmaceutical services performed by pharmacists in the State of Paraná.
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of clinical services in the community pharmacy, will have 
a tendency to change this situation in the long term.
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